Baker Bros. Advisors LP Xencor Inc Transaction History
Baker Bros. Advisors LP
- $9.34 Billion
- Q3 2024
A detailed history of Baker Bros. Advisors LP transactions in Xencor Inc stock. As of the latest transaction made, Baker Bros. Advisors LP holds 670,431 shares of XNCR stock, worth $13.2 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
670,431
Previous 545,431
22.92%
Holding current value
$13.2 Million
Previous $10.3 Million
30.58%
% of portfolio
0.14%
Previous 0.14%
Shares
11 transactions
Others Institutions Holding XNCR
# of Institutions
216Shares Held
71.5MCall Options Held
2.5KPut Options Held
7.9K-
Black Rock Inc. New York, NY11.1MShares$218 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA9.14MShares$180 Million0.14% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.6MShares$149 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.33MShares$105 Million4.65% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.93MShares$77.2 Million0.01% of portfolio
About Xencor Inc
- Ticker XNCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,698,100
- Market Cap $1.17B
- Description
- Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...